BioBam Bioinformatics
BioBam Bioinformatics is a Valencia-based software company that builds OmicsBox, a no-code NGS bioinformatics platform used by over 15,000 researchers at 900+ institutions for genomics, transcriptomics, metagenomics, and functional annotation.
- Company typePrivate
- Founded2011
- HeadquartersValencia, Spain
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What BioBam Bioinformatics does
BioBam Bioinformatics S.L. is a privately held bioinformatics software company founded in 2011 and headquartered in Valencia, Spain, that develops OmicsBox, an all-in-one desktop and cloud platform for next-generation sequencing (NGS) data analysis across genomes, transcriptomes, and metagenomes. The platform is built around five modular analysis capabilities (Functional Analysis, Transcriptomics, Genetic Variation, Metagenomics, and Genome Analysis) and incorporates the company's well-established Blast2GO functional annotation methodology, which is cited in over 7,000 scientific publications and is particularly used in non-model organism research. Technology components include Blast2GO for functional annotation, OmicsCloud for scalable cloud computation billed via Cloud Units, OmicsBox Web as a browser-based companion, a Common Workflow Language (CWL) workflow composer, BUSCO completeness assessment, CellKb single-cell cell-type annotation, and the recently introduced OmicsAI layer for AI-assisted result summarization.
The company monetizes primarily through annual OmicsBox subscriptions that bundle desktop and cloud access with all modules, supported by a 7-day free trial that drives self-serve conversion. Secondary revenue streams include freemium Blast2GO Basic, paid Blast2GO PRO licensing, usage-based Cloud Units for cloud computation, and royalty-style licensing from Blast2GO PRO plugins embedded in QIAGEN's CLC Genomics Workbench and Biomatters' Geneious platforms. BioBam serves a globally distributed customer base of over 15,000 researchers across more than 900 institutions, with a heavy skew toward academic and public-sector research organizations (universities, government labs) and additional use cases in agricultural genomics, microbiology, environmental NGS, and commercial biotech/pharma research. The company operates without disclosed external institutional funding and is led by founder-CEO Dr. Stefan Götz, with a lean team of 1-10 employees.
BioBam Bioinformatics firmographics
Firmographics- Name
- BioBam Bioinformatics
- Legal name
- BioBam Bioinformatics S.L.
- Website
- https://biobam.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- BioBam Bioinformatics is a Valencia-based software company that builds OmicsBox, a no-code NGS bioinformatics platform used by over 15,000 researchers at 900+ institutions for genomics, transcriptomics, metagenomics, and functional annotation.
- Ownership category
- akta.pro rank
BioBam Bioinformatics industry classification
Industry- Product category
- Bioinformatics Software
- NAICS
- Computer Systems Design and Related Services (5415), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Prepackaged Software (7372), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)
- akta.pro secondary industries
- Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics) (HLAAANAF), Single-Cell & Spatial Omics Discovery Platforms (target ID/validation, functional profiling) (HLAAAIAF), Genomic & Multi-Omic Biomarkers (NGS panels, transcriptomics, proteomics, metabolomics) (HLAAAMAJ)
Keywords
Where BioBam Bioinformatics is headquartered
LocationHeadquarters
- HQ city
- Valencia
- HQ country
- Spain
- HQ region
- Europe
Offices1 record
Markets served
BioBam Bioinformatics business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Revenue model
- OmicsBox Software Subscription: Annual and multi-year subscription licensing for OmicsBox, the company's flagship all-in-one NGS bioinformatics analysis platform. Includes desktop application, cloud computation credits (Cloud Units), and access to all modules (Functional Analysis, Transcriptomics, Genetic Variation, Metagenomics, Genome Analysis). Subscriptions are managed via a dashboard and include free updates and improvements.
- Blast2GO Licensing: Blast2GO software licensing, including Blast2GO Basic (free registration tier), Blast2GO PRO plugin for CLC Genomics Workbench and Geneious platforms, and command-line tools. Blast2GO Basic is freemium with limited features; PRO extends capabilities for professional use.
- Cloud Units / Pay-as-you-go Computation: Cloud computation credits (Cloud Units) for running analyses on OmicsCloud. Users can purchase Cloud Units to process large datasets on cloud infrastructure. Cloud Units balance is displayed in the account dashboard with options to recharge.
- Plugin and Integration Licensing: Licensing revenue from Blast2GO PRO plugins integrated into third-party platforms such as CLC Genomics Workbench (QIAGEN) and Geneious (Biomatters). Introductory pricing and promotional offers are used to drive adoption.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Freemium | Pay-as-you-go | 7-Day Free Trial |
| Subscription | Annual | OmicsBox Annual Subscription |
| Freemium | Pay-as-you-go | Blast2GO Basic |
| Usage-based | Pay-as-you-go | Cloud Units (OmicsCloud) |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
BioBam Bioinformatics product offering
Product offeringCore offering
BioBam develops and sells OmicsBox, an all-in-one desktop and cloud bioinformatics platform that delivers end-to-end NGS data analysis across five integrated modules — Functional Analysis (with the Blast2GO methodology), Transcriptomics, Genetic Variation, Metagenomics, and Genome Analysis — without requiring users to write code. The platform is complemented by OmicsCloud for scalable compute, OmicsBox Web for browser-based access, and Blast2GO PRO plugins distributed inside third-party platforms such as QIAGEN CLC Genomics Workbench and Biomatters Geneious.
Product overview
BioBam Bioinformatics offers OmicsBox as its primary all-in-one bioinformatics software solution, which provides end-to-end NGS data analysis through five integrated modules: Functional Analysis (including Blast2GO methodology), Transcriptomics, Genetic Variation, Metagenomics, and Genome Analysis. The platform is complemented by cloud-based offerings including OmicsCloud for scalable computation and OmicsBox Web for browser-based access. Blast2GO remains available as a standalone functional annotation tool and through plugin integrations for third-party platforms (Geneious, CLC Genomics Workbench). OmicsAI represents the company's initiative to integrate AI capabilities for results summarization and insight generation.
Differentiator
Problem solved
Functional benefit
Brands
- OmicsBox: All-in-one bioinformatics solution for NGS data analysis of genomes, transcriptomes, and metagenomes with modules for Functional Analysis, Transcriptomics, Genetic Variation, Metagenomics, and Genome Analysis.
- Blast2GO
- OmicsCloud
- OmicsAI
Products and services
- OmicsBox All-in-one desktop and cloud bioinformatics software for end-to-end NGS data analysis of genomes, transcriptomes, and metagenomes, organized into five integrated modules. Designed for life sciences researchers in academia, government, and industry who need to perform publication-grade analyses without writing code.
- OmicsCloud Cloud computation platform that runs OmicsBox analyses on demand, providing scalable compute resources, cloud storage, job monitoring, and result visualization via the companion OmicsBox Web application. Sold to researchers and labs that need to process large NGS datasets without provisioning their own infrastructure.
- OmicsBox Web Browser-based companion to OmicsBox that gives subscribers access to cloud storage, job monitoring, and result visualization from any web browser, complementing the desktop application for hybrid local/cloud workflows.
- Blast2GO Standalone functional annotation tool for novel sequence data, particularly for non-model organisms, based on the Blast2GO methodology. Includes a free Blast2GO Basic tier with registration and a Blast2GO PRO tier with extended capabilities, plus command-line tools. Now largely integrated into OmicsBox and offered alongside it for plugin-based distribution.
- OmicsAI Artificial intelligence module integrated into OmicsBox that uses generative AI to produce summaries and insights from bioinformatics analysis results, supporting interpretation and discovery workflows for OmicsBox subscribers.
- Blast2GO PRO Plugin for QIAGEN CLC Genomics Workbench OEM plugin that embeds Blast2GO PRO functional annotation inside the QIAGEN CLC Genomics Workbench bioinformatics platform, sold to existing CLC users working on non-model organism genomes and transcriptomes.
- Blast2GO PRO Plugin for Biomatters Geneious OEM plugin that brings Blast2GO PRO functional annotation into the Biomatters Geneious platform, enabling molecular biologists to comprehensively annotate and interpret novel sequences within Geneious.
Quantifiable outcome
- Over 7000 scientific research citations for Blast2GO methodology, demonstrating its established role in functional genomics research
- +2 more outcomes
Companies that use BioBam Bioinformatics
Customer profileNamed customers10 records
Segments5 records
Ideal customer profiles3 records
BioBam Bioinformatics technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration8 records
AI capability2 records
Feature9 records
BioBam Bioinformatics partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core and minor.
- Biomatters (Geneious)coreBioBam and Biomatters launched the Blast2GO PRO Plugin for the Geneious platform in July 2015. The plugin provides functional annotation and analysis of genomics datasets within Geneious, allowing molecular biologists to comprehensively annotate and interpret novel sequences. The plugin was offered at a 30% introductory discount during July 2015. Dr. Stefan Götz, CEO at BioBam, called the collaboration 'a great opportunity' to integrate Blast2GO seamlessly into the Geneious Plugin Dev-Kit ecosystem.
- CLC bio (now QIAGEN)coreIn October 2013, CLC bio (now part of QIAGEN) and BioBam announced an integrated workflow combining the Blast2GO PRO plugin with CLC Genomics Workbench. This allows researchers to perform NGS data quality control, assembly, genome-wide functional annotations, and interpretation of genomes and transcriptomes on a single integrated platform. The partnership targets researchers working with non-model organisms without reference sequences. BioBam's Dr. Stefan Götz, General Manager, managed this partnership at the time.
- LongTREC (ITN - Innovative Training Networks)minorBioBam is a member of LongTREC, a European ITN (Innovative Training Networks) initiative focused on advancing long-read transcriptomics. BioBam hosts secondments for the project and contributes to advancing long-read RNA-seq analysis capabilities, including integration of tools like FLAIR and IsoQuant into OmicsBox.
- INTERCEPT-MDS (European ITN)minorBioBam participates as a partner in INTERCEPT-MDS, a European ITN initiative. BioBam's involvement connects the company with academic researchers and provides opportunities for collaborative development of bioinformatics tools relevant to the ITN's research scope.
- BIOVALSA (Innovative Valorization of Plant Biomass Waste)minorBioBam joined BIOVALSA, a project focused on innovative valorization of plant biomass waste in Valencia for functional bioplastic production. This partnership extends BioBam's reach into sustainable biotechnology applications, leveraging bioinformatics for agricultural and environmental genomics.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
BioBam Bioinformatics competitors and assessment
Company assessmentDirect peers
- DNAnexus: DNAnexus provides a cloud-native bioinformatics platform used by major genomics consortia and pharma for NGS analysis pipelines — the same workflow orchestration space OmicsBox targets with OmicsCloud.
- Velsera (formerly Seven Bridges): Velsera operates a cloud bioinformatics platform supporting genomics, transcriptomics, and multi-omics workflows, competing with OmicsBox/OmicsCloud in translational and pharma-oriented research environments.
- Partek (Illumina): Partek Flow and Partek Genomics Suite provide GUI-based NGS analysis for genomics, transcriptomics, and variant analysis, competing head-to-head with OmicsBox for the same 'no-coding-required' academic and translational research market.
- Galaxy Project: Galaxy is an open-source web-based platform for accessible NGS analysis, a free alternative that competes directly with OmicsBox in academic bioinformatics workflows.
- BlueBee: BlueBee offers cloud-based bioinformatics analysis platforms for NGS data, including genomic and transcriptomic pipelines, serving academic and clinical research customers with shared SaaS positioning with OmicsCloud.
Emerging players
- Benchling: Benchling provides a cloud R&D platform spanning genomics and biologics; while broader than bioinformatics alone, it increasingly competes for the same biotech informatics budgets as OmicsBox in commercial settings.
Broad incumbents
- Illumina (BaseSpace, DRAGEN, Emedgene): Illumina offers BaseSpace Sequence Hub, DRAGEN secondary analysis, and Emedgene for clinical interpretation, operating broadly across NGS analysis as part of its sequencer ecosystem — overlapping with OmicsBox's pipelines.
- Thermo Fisher Scientific (Life Sciences Informatics): Thermo Fisher provides informatics tools and platforms supporting genomics and proteomics workflows across its broad life sciences portfolio, competing in the larger bioinformatics market.
Others
- Biomatters (Geneious): Geneious is a leading molecular biology analysis platform; BioBam partners with Biomatters for the Blast2GO PRO plugin, yet Geneious itself addresses overlapping NGS analysis users in academic workflows.
- QIAGEN Digital Insights (CLC Genomics Workbench): QIAGEN's CLC Genomics Workbench is a leading desktop NGS analysis platform; while BioBam has an OEM partnership (Blast2GO PRO plugin), it remains the closest comparable workflow competitor in functional genomics annotation.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
BioBam Bioinformatics social profiles
Digital presenceBioBam Bioinformatics compliance and trust
Trust signalCompliance2 records
BioBam Bioinformatics financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioBam Bioinformatics leadership team
Management profileNumber of profiles
Profiles1 record
BioBam Bioinformatics funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioBam Bioinformatics M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioBam Bioinformatics
What does BioBam Bioinformatics do?
BioBam develops and sells OmicsBox, an all-in-one desktop and cloud bioinformatics platform that delivers end-to-end NGS data analysis across five integrated modules — Functional Analysis (with the Blast2GO methodology), Transcriptomics, Genetic Variation, Metagenomics, and Genome Analysis — without requiring users to write code. The platform is complemented by OmicsCloud for scalable compute, OmicsBox Web for browser-based access, and Blast2GO PRO plugins distributed inside third-party platforms such as QIAGEN CLC Genomics Workbench and Biomatters Geneious.
Is BioBam Bioinformatics a public or private company?
BioBam Bioinformatics is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was BioBam Bioinformatics founded?
BioBam Bioinformatics was founded in 2011. It employs 1 to 10 people.
Where is BioBam Bioinformatics based?
BioBam Bioinformatics is headquartered in Valencia, Spain, in the Europe region.
How does BioBam Bioinformatics make money?
Four revenue lines are on record. OmicsBox Software Subscription is the primary driver. The others are blast2GO Licensing, cloud Units / Pay-as-you-go Computation and plugin and Integration Licensing.
Who are BioBam Bioinformatics's main competitors?
Direct peers on record are DNAnexus, Velsera (formerly Seven Bridges), Partek (Illumina), Galaxy Project and BlueBee. Benchling is listed as an emerging player. Broad incumbents are Illumina (BaseSpace, DRAGEN, Emedgene) and Thermo Fisher Scientific (Life Sciences Informatics). Others are Biomatters (Geneious) and QIAGEN Digital Insights (CLC Genomics Workbench).
Does BioBam Bioinformatics have an API?
No public API is recorded for BioBam Bioinformatics.
What industry is BioBam Bioinformatics in?
BioBam Bioinformatics's product category is Bioinformatics Software. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAAANAF, Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics). Its NAICS code is 5415 and its SIC code is 7372.